Since the NHS Jewish BRCA Testing Programme began in January 2023, around 11,000 saliva tests have been processed, with 235 people (2.1%) testing positive for a BRCA gene mutation, according to new ...

A quality initiative focused on BRCA and HRD testing and use of first line maintenance in advanced ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This ...

Should screening for BRCA1/2 mutations be expanded to all women diagnosed with breast cancer? This is the recommendation put forth in recent guidelines from the American Society of Clinical Oncology ...

Only 23.3% of ovarian cancer patients receive BRCA testing, leading to higher treatment costs and advanced therapy lines. Non-White and low-income patients face increased financial toxicity, ...

Last month, University College London Hospitals announced a new test for women at high risk of ovarian cancer due to inherited BRCA1 or BRCA2 gene mutations, who wish to defer preventative surgery. Dr ...

Over 20% of high-grade serous ovarian cancer patients have BRCA mutations, and up to 50% exhibit HRD, impacting DNA repair pathways. Global guidelines recommend BRCA and HRD testing, but many eligible ...